Showing 871 - 880 of 906
The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of medication labeling changes on brand pharmaceutical products, and whether and what firms do to respond to increased information regarding the safety and efficacy...
Persistent link: https://www.econbiz.de/10013092256
The Bureau of Labor Statistics' Prescription Drug Consumer Price Index (CPI-Rx) has been the focus of considerable controversy in recent years. The CPI-Rx limits its sampling frame to transactions in retail outpatient outlets, and excludes prescription pharmaceuticals dispensed in hospitals,...
Persistent link: https://www.econbiz.de/10013388804
Persistent link: https://www.econbiz.de/10013336495
We construct price indexes for treatment of a specific illness, acute phase major depression, using treatment episodes of care (rather than fixed input bundles) to define quantity. We identify different treatment service bundles that combine varying quantities of prescription drugs, medical...
Persistent link: https://www.econbiz.de/10013308473
In this paper we report results of an exploratory empirical effort examining relationships between investments in high-tech information technology capital and the distribution of employment, both by occupation and by level of educational attainment. Our data cover the two-digit U.S....
Persistent link: https://www.econbiz.de/10013310802
Persistent link: https://www.econbiz.de/10013416735
Persistent link: https://www.econbiz.de/10013418244
Persistent link: https://www.econbiz.de/10013481436
Persistent link: https://www.econbiz.de/10014252018